You searched for "erection"

962 results found

Drinks Reception: Latest data from the GALEAS Bladder NHS Real World Evaluation at BAUS (British Association of Urological Surgeons) 2025

Join the team behind GALEAS Bladder, the urinary biomarker test delivering results equivalent to a cystoscopy for the detection and monitoring of bladder cancer, along with special guests, to find out how GALEAS Bladder has performed in the NHS Real World Evaluation. 6 - 7pm, drinks and presentations 7pm onwards, drinks, networking and food

APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025

The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have...

A Revolution in your hands: Wellspect launch innovative new female catheter

Wellspect have been innovators in catheterisation since developing the world’s first hydrophilic catheter. Now the Swedish company look to revolutionise the way women learn and perform intermittent self-catheterisation (ISC).

Why defining and managing DUST matters in endourology

In endourology, defining ‘DUST’ and optimising its management is vital for improving stone-free rates (SFR) and reducing complications. Residual fragments, even those ≤4mm, can act as a nidus for infection, obstruction, and recurrence. Studies have shown that 30% of patients...

Urologic complications of radiotherapy

Case 1 1. What machine is seen in the picture? 2. What is the standard dose schedule for radiotherapy for prostate cancer? 3. What are the complications of radiotherapy? Case 2 1. How does haemorrhagic cystitis develop? 2. What are...

‘The Rise of a Specialty’ – Exhibition at the Royal Society of Medicine

The founding of the Royal Society of Medicine’s (RSM) Urology Section 100 years ago this year was crucial to the establishment of urology as a specialty in Great Britain in its own right. To mark this anniversary, earlier this year...

EAU (European Association of Urology) Masterclass on Focal therapy for localised prostate cancer

Focal Therapy (FT) is a promising treatment option aimed at improving the management of localised prostate cancer. This masterclass will provide you with an extensive review of the rationale for FT, the patient selection modalities and the available energy sources (HIFU, Cryo, IRE, Laser, Brachytherapy). Gain further knowledge and better understand the FT benefits.

RSM (Royal Society of Medicine) Complexity and Complications: Navigating Advanced Prostate Cancer

This year’s RSM Cancer Day will focus on the evolving management of prostate cancer. With emerging evidence supporting radical prostatectomy in oligometastatic disease, the programme will examine patient selection, treatment strategies, and the latest advances for managing advanced-stage cases.

Thulium laser: the new kid ‘en bloc’

Transurethral resection of bladder tumour (TURBT) is considered the gold standard for management of bladder cancer. Residual rates of 15-53% at second TURB and upstaging rates of 4-29% with muscle invasion have been reported. The quality and result of the...

Mechanisms and prevention of catheterisation associated urethral injury (CAUI)

Urethral catheterisation is a common procedure performed by health professionals across different grades and specialties in a variety of clinical settings. An estimated 15-25% of hospitalised patients have a urinary catheter inserted during their inpatient stay and up to 13%...

Retention after Botox therapy in OAB

Treatment of overactive bladder (OAB) has a wide spectrum. The first step is lifestyle modifications, the second step is pharmacotherapy and the third line is intradetrusor injections with Botox®. This retrospective study is from Tennessee, USA in non-neurogenic and refractory...

BCG after TURBT – does timing matter?

Intravesical bacille Calmette–Guerin (BCG) therapy continues to be widely used for patients with intermediate / high-risk non-muscle invasive bladder cancer (NMIBC). In this article, the researchers identified the lack of sufficient evidence with regards to timing of BCG after transurethral...